About Apollomics, Inc. 
Apollomics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 2 Schemes (1.11%)
Foreign Institutions
Held by 3 Foreign Institutions (0.06%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2022)
Net Profit:
0 Million
Pharmaceuticals & Biotechnology
USD 21 Million ()
NA (Loss Making)
NA
0.00%
0.43
938.56%
-4.86






